Published in Ann Hum Genet on September 01, 2016
GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol | NCT00158899
Regulation of Lipoprotein Transport in Metabolic Syndrome | NCT00841217
Study to Evaluate the Effects of MBX-8025 in Patients With HoFH | NCT02472535
PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92
KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res (2000) 117.00
BioGRID: a general repository for interaction datasets. Nucleic Acids Res (2006) 22.41
Multiple imputation using chained equations: Issues and guidance for practice. Stat Med (2010) 17.36
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med (2011) 13.55
Major lipids, apolipoproteins, and risk of vascular disease. JAMA (2009) 10.58
DIP: the database of interacting proteins. Nucleic Acids Res (2000) 10.06
Discovery and refinement of loci associated with lipid levels. Nat Genet (2013) 7.86
PPARs and the complex journey to obesity. Nat Med (2004) 7.44
Two-stage two-locus models in genome-wide association. PLoS Genet (2006) 5.60
Antiinflammatory properties of HDL. Circ Res (2004) 5.41
A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci U S A (2001) 4.22
Singapore Chinese Health Study: development, validation, and calibration of the quantitative food frequency questionnaire. Nutr Cancer (2001) 3.77
Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux. Mol Cell Biol (2002) 3.02
Increasing the power of identifying gene x gene interactions in genome-wide association studies. Genet Epidemiol (2008) 2.84
Biofilter: a knowledge-integration system for the multi-locus analysis of genome-wide association studies. Pac Symp Biocomput (2009) 2.26
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am J Hum Genet (2012) 1.96
The Collaborative Lipid Research Clinics Family Study: biological and cultural determinants of familial resemblance for plasma lipids and lipoproteins. Genet Epidemiol (1985) 1.95
Spatially uniform relieff (SURF) for computationally-efficient filtering of gene-gene interactions. BioData Min (2009) 1.75
Singapore Genome Variation Project: a haplotype map of three Southeast Asian populations. Genome Res (2009) 1.73
PPARdelta regulates multiple proinflammatory pathways to suppress atherosclerosis. Proc Natl Acad Sci U S A (2008) 1.68
Rationale and methodology for a population-based study of eye diseases in Malay people: The Singapore Malay eye study (SiMES). Ophthalmic Epidemiol (2007) 1.68
PolymiRTS Database 3.0: linking polymorphisms in microRNAs and their target sites with human diseases and biological pathways. Nucleic Acids Res (2013) 1.67
Methodology of the Singapore Indian Chinese Cohort (SICC) eye study: quantifying ethnic variations in the epidemiology of eye diseases in Asians. Ophthalmic Epidemiol (2009) 1.64
Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons. Cardiovasc Diabetol (2005) 1.61
Rank-based inverse normal transformations are increasingly used, but are they merited? Behav Genet (2009) 1.55
Genetic causes of high and low serum HDL-cholesterol. J Lipid Res (2010) 1.55
Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects. Diabetologia (2000) 1.54
Is there a clear threshold for fasting plasma glucose that differentiates between those with and without neuropathy and chronic kidney disease?: the Singapore Prospective Study Program. Am J Epidemiol (2009) 1.23
The role of PPARs in atherosclerosis. Trends Mol Med (2002) 1.22
The effect of PPAR-alpha agonism on apolipoprotein metabolism in humans. Atherosclerosis (2009) 1.17
The tetraspan protein EMP2 modulates the surface expression of caveolins and glycosylphosphatidyl inositol-linked proteins. Mol Biol Cell (2004) 1.13
Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells. Oncogene (2003) 1.12
The antiatherogenic role of high-density lipoprotein cholesterol. Am J Cardiol (1998) 1.09
Role of prostacyclin versus peroxisome proliferator-activated receptor beta receptors in prostacyclin sensing by lung fibroblasts. Am J Respir Cell Mol Biol (2005) 1.08
Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus. Curr Diabetes Rev (2007) 1.07
Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men. J Intern Med (2003) 1.06
Effect of niacin on LXRalpha and PPARgamma expression and HDL-induced cholesterol efflux in adipocytes of hypercholesterolemic rabbits. Int J Cardiol (2007) 1.01
The tetraspan protein EMP2 regulates expression of caveolin-1. J Biol Chem (2007) 0.99
Novel benefits of peroxisome proliferator-activated receptors on cardiovascular risk. Curr Opin Lipidol (2013) 0.95
Mutations in EMP2 cause childhood-onset nephrotic syndrome. Am J Hum Genet (2014) 0.95
Rosiglitazone upregulates caveolin-1 expression in THP-1 cells through a PPAR-dependent mechanism. J Lipid Res (2004) 0.93
Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity. J Clin Endocrinol Metab (2011) 0.91
The V227A polymorphism at the PPARA locus is associated with serum lipid concentrations and modulates the association between dietary polyunsaturated fatty acid intake and serum high density lipoprotein concentrations in Chinese women. Atherosclerosis (2005) 0.91
Effects of the PPAR-δ agonist MBX-8025 on atherogenic dyslipidemia. Atherosclerosis (2011) 0.91
Lipid effects of peroxisome proliferator-activated receptor-δ agonist GW501516 in subjects with low high-density lipoprotein cholesterol: characteristics of metabolic syndrome. Arterioscler Thromb Vasc Biol (2012) 0.89
Plasma carotenoids and risk of acute myocardial infarction in the Singapore Chinese Health Study. Nutr Metab Cardiovasc Dis (2010) 0.89
Diagnosis of diabetes mellitus using HbA1c in Asians: relationship between HbA1c and retinopathy in a multiethnic Asian population. J Clin Endocrinol Metab (2014) 0.88
Prevalence, racial variations, and risk factors of age-related macular degeneration in Singaporean Chinese, Indians, and Malays. Ophthalmology (2014) 0.87
Features of the metabolic syndrome are modulated by an interaction between the peroxisome proliferator-activated receptor-delta -87T>C polymorphism and dietary fat in French-Canadians. Int J Obes (Lond) (2006) 0.87
Meta-analysis of genome-wide association studies in multiethnic Asians identifies two loci for age-related nuclear cataract. Hum Mol Genet (2014) 0.86
ABCA1 modulates the oligomerization and Golgi exit of caveolin-1 during HDL-mediated cholesterol efflux in aortic endothelial cells. Biochem Biophys Res Commun (2009) 0.84
Ligand-dependent transcriptional activities of four torafugu pufferfish Takifugu rubripes peroxisome proliferator-activated receptors. Gen Comp Endocrinol (2007) 0.83
High incidence of reduced plasma HDL cholesterol in diabetic patients treated with rosiglitazone and fibrate. Pharmacoepidemiol Drug Saf (2007) 0.82
Severe acquired (secondary) high-density lipoprotein deficiency. J Clin Lipidol (2007) 0.82
Are C-reactive protein associated genetic variants associated with serum levels and retinal markers of microvascular pathology in Asian populations from Singapore? PLoS One (2013) 0.81
PPARδ promotes oncogenic redirection of TGF-β1 signaling through the activation of the ABCA1-Cav1 pathway. Cell Cycle (2013) 0.78
Severe decrease in serum HDL-cholesterol during combination therapy of bezafibrate and pioglitazone. J Atheroscler Thromb (2006) 0.78
Severe hypo-alpha-lipoproteinemia during treatment with rosiglitazone. Diabetes Care (2004) 0.78
PPARα gene polymorphisms modulate the association between physical activity and cardiometabolic risk. Nutr Metab Cardiovasc Dis (2014) 0.78
Conditional Expression of Human PPARδ and a Dominant Negative Variant of hPPARδ In Vivo. PPAR Res (2012) 0.77
PPARγ2 gene Pro12Ala and PPARα gene Leu162Val single nucleotide polymorphisms interact with dietary intake of fat in determination of plasma lipid concentrations. J Nutrigenet Nutrigenomics (2012) 0.77
Differential effects of n-3 and n-6 fatty acids on prostaglandin F2alpha production by bovine endometrial cells. J Dairy Sci (2006) 0.76
The peroxisome proliferator-activated receptor delta +294T > C polymorphism and alcohol consumption on serum lipid levels. Lipids Health Dis (2011) 0.76
HDL in risk prediction and its direct and indirect involvement in atherogenesis. Atheroscler Suppl (2002) 0.76
Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation. Nat Genet (2015) 1.28
The impact of genome wide supported microRNA-137 (MIR137) risk variants on frontal and striatal white matter integrity, neurocognitive functioning, and negative symptoms in schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2015) 0.81
A genome-wide association study of n-3 and n-6 plasma fatty acids in a Singaporean Chinese population. Genes Nutr (2015) 0.80
Genome-wide association studies in East Asians identify new loci for waist-hip ratio and waist circumference. Sci Rep (2016) 0.79
Utility of genetic and non-genetic risk factors in predicting coronary heart disease in Singaporean Chinese. Eur J Prev Cardiol (2016) 0.77
Interaction effects between Paraoxonase 1 variants and cigarette smoking on risk of coronary heart disease in a Singaporean Chinese population. Atherosclerosis (2015) 0.76
HDL-cholesterol levels and risk of age-related macular degeneration: a multiethnic genetic study using Mendelian randomization. Int J Epidemiol (2017) 0.75
Association analyses of East Asian individuals and trans-ancestry analyses with European individuals reveal new loci associated with cholesterol and triglyceride levels. Hum Mol Genet (2017) 0.75
Association of modified NUTRIC score with 28-day mortality in critically ill patients. Clin Nutr (2016) 0.75